Menetrier's disease therapy: rebooting mucosal signaling

Sci Transl Med. 2009 Nov 25;1(8):8ps10. doi: 10.1126/scitranslmed.3000438.


Ménétrier's disease, a rare hyperproliferative disorder of the stomach, is associated with chronic abdominal pain, vomiting, weight loss, and edema, as well as an increased risk of gastric cancer. Therapy, other than surgical resection of the stomach, is limited to supportive measures and reflects the limited understanding of Ménétrier's disease pathogenesis. Data reported in this issue describe a promising targeted therapeutic approach and provide new insight into the causes of Ménétrier's disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Animals
  • Cats
  • ErbB Receptors / metabolism
  • Gastric Mucosa / metabolism*
  • Gastritis, Hypertrophic / metabolism
  • Gastritis, Hypertrophic / therapy*
  • Humans
  • Signal Transduction*


  • ErbB Receptors